Table 3.

TTP for the global RV and six segments of the RV in healthy controls and PE patients with and without PH before and after treatment

TTP (ms)	Healthy control (n = 40)	PE without PH before treatment (n = 39)	PE with PH before treatment (n = 34)	PE without PH after treatment (n = 39)	PE with PH after treatment (n = 34)
Global	− 23.62 ± 3.49	− 15.49 ± 3.57△	− 12.45 ± 4.06△	− 21.02 ± 5.12	− 19.53 ± 6.44*
Basal free wall	− 28.29 ± 8.43	− 17.08 ± 5.44△	− 16.82 ± 5.41△	− 26.47 ± 6.89	− 24.33 ± 7.53*
Mid free wall	− 27.49 ± 7.61	− 18.92 ± 6.03△	− 16.74 ± 6.28△	− 24.56 ± 6.37	− 22.72 ± 6.51*
Apical free wall	− 25.51 ± 9.07	− 17.11 ± 5.75△	− 14.88 ± 7.08△	− 21.48 ± 7.56	− 20.84 ± 6.42*
Basal septum	− 18.44 ± 4.26	− 12.68 ± 5.76△	− 9.43 ± 4.52△	− 16.03 ± 6.92	− 15.01 ± 5.23*
Mid septum	− 19.15 ± 4.31	− 16.31 ± 4.45*	− 11.74 ± 7.14△	− 17.54 ± 5.43	− 15.67 ± 6.82*
Apical septum	− 20.21 ± 5.87	− 16.44 ± 6.27*	− 13.68 ± 7.59△	− 18.13 ± 6.24	− 16.17 ± 7.46*

Data are expressed as $\overline{x}\pm S$

RV right ventricular, PE pulmonary embolism, PH pulmonary hypertension, TTP time to PLSS

Compared to control group, *P < 0.05, ^△P < 0.01